Cargando…
Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
Manufacturing procedures for cellular therapies are continuously improved with particular emphasis on product safety. We previously developed a dendritic cell (DC) cancer vaccine technology platform that uses clinical grade lipopolysaccharide (LPS) and interferon (IFN)-y for the maturation of monocy...
Autores principales: | Dohnal, Alexander Michael, Graffi, Sebastian, Witt, Volker, Eichstill, Christina, Wagner, Dagmar, Ul-Haq, Sidrah, Wimmer, Doris, Felzmann, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823041/ https://www.ncbi.nlm.nih.gov/pubmed/18363835 http://dx.doi.org/10.1111/j.1582-4934.2008.00304.x |
Ejemplares similares
-
Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode
por: Luger, Romana, et al.
Publicado: (2013) -
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
por: Erhart, Friedrich, et al.
Publicado: (2018) -
Rheological Issues in Carbon-Based Inks for Additive Manufacturing
por: O’ Mahony, Charlie, et al.
Publicado: (2019) -
Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020) -
Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment
por: Hopewell, Emily L., et al.
Publicado: (2020)